Rare diseases
Investigational molecules
Locations
Back to Germany357 clinical trials in Mannheim, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
GermanyStudy on ACOU085 to Prevent Hearing Loss in Testicular Cancer Patients Receiving Cisplatin
GermanyStudy of RVT-3101 for Treating Moderate to Severe Crohn's Disease in Patients
GermanyStudy of Pembrolizumab and Lenvatinib for Patients with Advanced or Recurrent Endometrial Cancer
GermanyStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
GermanyStudy of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer
GermanyStudy Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels
GermanyStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
GermanyStudy on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments
GermanyStudy of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer
GermanyStudy on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on Alzheimer's Disease and ALS, including trials of new therapeutic compounds for early-stage dementia and innovative treatments for motor neuron disease.
Research aims to improve brain amyloid clearance and evaluate new treatment approaches for neurological disorders.
Comprehensive studies in cancer treatment, including trials for gastric cancer, melanoma, and breast cancer, with a focus on targeted therapies and immunological approaches.
Advanced treatments combining immunotherapy with established protocols to improve patient outcomes.
Studies addressing inflammatory disorders, particularly focusing on Crohn's Disease, ulcerative colitis, and uveitis, testing novel therapeutic combinations.
Innovative treatment strategies aimed at improving disease management and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
